BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15832592)

  • 1. Therapy of chronic hepatitis C in the setting of HIV co-infection.
    Michielsen P; Bottieau E
    Acta Gastroenterol Belg; 2005; 68(1):86-91. PubMed ID: 15832592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV and hepatitis C co-infection].
    Vogel M; Boesecke C; Wasmuth JC; Rockstroh JK
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1186-91. PubMed ID: 20514600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.
    Campos NG; Salomon JA; Servoss JC; Nunes DP; Samet JH; Freedberg KA; Goldie SJ
    Am J Med; 2007 Mar; 120(3):272-9. PubMed ID: 17349451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications].
    Jabłonowska E
    Przegl Epidemiol; 2004; 58(4):621-8. PubMed ID: 15810503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
    Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
    Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases.
    Vogel M; Bieniek B; Jessen H; Schewe CK; Hoffmann C; Baumgarten A; Kroidl A; Bogner JR; Spengler U; Rockstroh JK
    J Viral Hepat; 2005 Mar; 12(2):207-11. PubMed ID: 15720537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.
    Romero M; Pérez-Olmeda M; García-Samaniego J; Soriano V
    Drug Saf; 2004; 27(1):7-24. PubMed ID: 14720084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating hepatitis C in HIV-HCV coinfected patients.
    Tossing G
    Infection; 2002 Oct; 30(5):329-31. PubMed ID: 12420736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
    Colson P; Bregigeon S; Tourres C; Solas C; Poizot-Martin I; Tamalet C
    J Clin Virol; 2013 Sep; 58(1):309-14. PubMed ID: 23810614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in HIV-infected patients--therapeutic approach.
    Fernández I; Rubio R; Lumbreras C
    Clin Microbiol Infect; 2002 Feb; 8(2):80-4. PubMed ID: 11952720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
    Inglot M; Szymczak A; Gasiorowski J
    Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices.
    Weiss JJ; Morgello S
    Gen Hosp Psychiatry; 2009; 31(6):531-7. PubMed ID: 19892211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the management of HIV and hepatitis C virus co-infection.
    Lee W; Dieterich D
    Drugs; 2004; 64(7):693-700. PubMed ID: 15025544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.
    Lo Re V; Kostman JR; Amorosa VK
    Clin Liver Dis; 2008 Aug; 12(3):587-609, ix. PubMed ID: 18625430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.